Quantcast

Latest GlaxoSmithKline Stories

2014-09-11 08:28:56

Accomplished trio join a Board managing the challenges and opportunities of growth WORCESTER, Mass., Sept. 11, 2014 /PRNewswire-USNewswire/ -- Wake Up Narcolepsy (WUN), a nonprofit organization working to improve the lives of people living with narcolepsy, today announced the appointment of three new members of its Board of Directors, effective immediately. http://photos.prnewswire.com/prnvar/20140910/145218 Raymond De Rise has extensive legal and compliance experience in the...

2014-09-11 04:21:18

OXFORD, England, September 11, 2014 /PRNewswire/ -- Successful Completion of Biomedical Catalyst Programme Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that it has confirmed the potential of its Multi-component Particle(TM) (MCP(TM)) Technology for creating novel inhaled, dual and triple fixed dose combination (FDC) therapies for respiratory diseases. The Company...

2014-09-08 16:25:06

DALLAS, September 8, 2014 /PRNewswire/ -- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates is a 266 pages, 2014 market research report now available with ReportsnReports.com at http://www.reportsnreports.com/reports/297438-countryfocus-healthcare-regulatory-and-reimbursement-landscape-united-arab-emirates.html . This research says the United Arab Emirates (UAE) is second only to Saudi Arabia in terms of pharmaceutical investment in...

2014-09-05 08:23:21

PITTSBURGH, Sept. 5, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Ibandronate Sodium Injection, 1 mg (base)/mL, packaged in 3 mg (base)/3 mL pre-filled glass syringes, which is the generic version of Hoffmann-La Roche's Boniva® Injection. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of osteoporosis in...

2014-09-04 16:26:50

PARSIPPANY, N.J., Sept. 4, 2014 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare applauds CVS for its courageous decision to end the sale of tobacco products. This monumental step will go a long way towards improving and protecting public health. Banning the sale of cigarettes and other harmful tobacco products from its shelf will help CVS encourage current smokers to quit, may prevent potential smokers from starting the deadly habit and may ultimately reduce the prevalence...

2014-09-03 16:30:04

EDISON, N.J., Sept. 3, 2014 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc. (OTCBB:CTRV), an emerging biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today it will present at two upcoming investor conferences. ContraVir is scheduled to present at the Rodman & Renshaw 16(th) Annual Global Investment Conference, to be held September 8-10, 2014, in New York City, and the Aegis Capital 2014 Healthcare and Technology...

2014-09-02 04:21:24

QXFORD, England, September 2, 2014 /PRNewswire/ -- Triggers milestone payment from Mylan Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that its Marketing Authorisation Application (MAA) for PSX1001 has been validated and is being assessed under the Decentralised Procedure (DCP), in which the UK's Medicines and Healthcare Products Regulatory Agency (MHRA) is...

2014-08-28 12:30:58

RnRMarketResearch.com adds "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland" & "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Turkey" to its store. DALLAS, Aug. 28, 2014 /PRNewswire-iReach/ -- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Poland (Photo - http://photos.prnewswire.com/prnh/20140828/140879) The report "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Poland" an essential source of information and...

2014-08-26 12:29:13

DUBLIN, Aug. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Intranasal Drug Delivery Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. The nose is considered to be an ideal administrative route...

2014-08-25 08:28:30

Multimedia assets associated with the below announcement are now available. Assets include: b-roll footage, corporate sound bites, product images and additional information. Please click: http://www.multivu.com/players/English/7197331-viiv-healthcare-vhc-triumeq-fda-approval LONDON, Aug. 25, 2014 /PRNewswire/ -- On August 22, ViiV Healthcare announced that the US Food and Drug Administration (FDA) approved Triumeq(®) (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related